Chapter 1. TRAVEL VACCINES MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. TRAVEL VACCINES MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. TRAVEL VACCINES MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. TRAVEL VACCINES MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. TRAVEL VACCINES MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. TRAVEL VACCINES MARKET – by Vaccine Type
6.1. Influenza
6.2. Hepatitis B
6.3. Japanese Encephalitis
6.4. Yellow Fever
6.5. Typhoid
6.6. Meningococcal
6.7. Rabies
6.8. Hepatitis A
6.9. Cholera
6.10. Tick-borne Encephalitis
6.11. Others
Chapter 7. TRAVEL VACCINES MARKET – By Distribution Channel
7.1. Clinics
7.2. Hospitals
7.3. Retail Pharmacies
7.4. Online Channels
Chapter 8. TRAVEL VACCINES MARKET – By Region
8.1. North America
8.2. Europe
8.3.The Asia Pacific
8.4.Latin America
8.5. Middle-East and Africa
Chapter 9. TRAVEL VACCINES MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
9.1. Company 1
9.2. Company 2
9.3. Company 3
9.4. Company 4
9.5. Company 5
9.6. Company 6
9.7. Company 7
9.8. Company. 8
9.9. Company 9
9.10. Company 10
2850
5250
4500
1800